BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 38640287)

  • 21. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.
    Ludmir EB; Milgrom SA; Pinnix CC; Gunther JR; Westin J; Fayad LE; Khoury JD; Medeiros LJ; Dabaja BS; Nastoupil LJ
    Clin Lymphoma Myeloma Leuk; 2019 Apr; 19(4):244-250. PubMed ID: 30686775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy.
    Zucca E; Conconi A; Martinelli G; Bouabdallah R; Tucci A; Vitolo U; Martelli M; Pettengell R; Salles G; Sebban C; Guillermo AL; Pinotti G; Devizzi L; Morschhauser F; Tilly H; Torri V; Hohaus S; Ferreri AJM; Zachée P; Bosly A; Haioun C; Stelitano C; Bellei M; Ponzoni M; Moreau A; Jack A; Campo E; Mazzucchelli L; Cavalli F; Johnson P; Thieblemont C
    J Clin Oncol; 2017 Jun; 35(17):1905-1912. PubMed ID: 28355112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism.
    Du MQ
    Best Pract Res Clin Haematol; 2017; 30(1-2):13-23. PubMed ID: 28288707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral MALT Lymphoma of the Breast.
    González López A; Del Riego J; Martín A; Rodríguez A; Javier Andreu F; Piernas S; Sentís M
    Breast J; 2017 Jul; 23(4):471-473. PubMed ID: 28185346
    [No Abstract]   [Full Text] [Related]  

  • 25. MALT lymphoma: A paradigm of NF-κB dysregulation.
    Du MQ
    Semin Cancer Biol; 2016 Aug; 39():49-60. PubMed ID: 27452667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary MALT Lymphoma of the Breast Treated with Definitive Radiation.
    Hissourou Iii M; Zia SY; Alqatari M; Strauchen J; Bakst RL
    Case Rep Hematol; 2016; 2016():1831792. PubMed ID: 27247809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
    Raderer M; Kiesewetter B; Ferreri AJ
    CA Cancer J Clin; 2016; 66(2):153-71. PubMed ID: 26773441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
    Ruskoné-Fourmestraux A; Matysiak-Budnik T; Fabiani B; Cervera P; Brixi H; Le Malicot K; Nion-Larmurier I; Fléjou JF; Hennequin C; Quéro L;
    Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up.
    Raderer M; Wöhrer S; Kiesewetter B; Dolak W; Lagler H; Wotherspoon A; Muellauer L; Chott A
    Ann Hematol; 2015 Jun; 94(6):969-73. PubMed ID: 25579756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma.
    Kim DH; Jeong JY; Lee SW; Lee J; Ahn BC
    Clin Nucl Med; 2015 Feb; 40(2):e148-9. PubMed ID: 25140550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary Breast Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Transformation to Diffuse Large B-cell Lymphoma: A Case Report.
    Arslan SH; Uyetürk U; Tekgündüz E; Irkkan SÇ; Kurt MY; Demiriz IŞ; Altuntaş F
    Turk J Haematol; 2012 Sep; 29(3):274-7. PubMed ID: 24744673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective comparison of the effectiveness of various treatment modalities of extragastric MALT lymphoma: a single-center analysis.
    Wöhrer S; Kiesewetter B; Fischbach J; Müllauer L; Troch M; Lukas J; Mayerhoefer ME; Raderer M
    Ann Hematol; 2014 Aug; 93(8):1287-95. PubMed ID: 24633660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
    Flinn IW; van der Jagt R; Kahl BS; Wood P; Hawkins TE; Macdonald D; Hertzberg M; Kwan YL; Simpson D; Craig M; Kolibaba K; Issa S; Clementi R; Hallman DM; Munteanu M; Chen L; Burke JM
    Blood; 2014 May; 123(19):2944-52. PubMed ID: 24591201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EBV-positive low-grade marginal zone lymphoma in the breast with massive amyloid deposition arising in a heart transplant patient: A report of an unusual case.
    Nassif S; Ozdemirli M
    Pediatr Transplant; 2013 Sep; 17(6):E141-5. PubMed ID: 23773403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
    Rummel MJ; Niederle N; Maschmeyer G; Banat GA; von Grünhagen U; Losem C; Kofahl-Krause D; Heil G; Welslau M; Balser C; Kaiser U; Weidmann E; Dürk H; Ballo H; Stauch M; Roller F; Barth J; Hoelzer D; Hinke A; Brugger W;
    Lancet; 2013 Apr; 381(9873):1203-10. PubMed ID: 23433739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expect the unexpected: primary breast MALT lymphoma.
    Ghetu D; Membrez V; Bregy A; Vees HG; Hottelier D; Girardet C; Schneider N; Bieri S
    Arch Gynecol Obstet; 2011 Nov; 284(5):1323-4. PubMed ID: 21800083
    [No Abstract]   [Full Text] [Related]  

  • 37. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.
    Ruskoné-Fourmestraux A; Fischbach W; Aleman BM; Boot H; Du MQ; Megraud F; Montalban C; Raderer M; Savio A; Wotherspoon A;
    Gut; 2011 Jun; 60(6):747-58. PubMed ID: 21317175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary breast lymphomas.
    Julen O; Dellacasa I; Pelte MF; Borish B; Bouchardy C; Capanna F; Vlastos G; Dubuisson JB; Vlastos AT
    Rare Tumors; 2009 Jul; 1(1):e14. PubMed ID: 21139885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Zucca E; Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v175-6. PubMed ID: 20555074
    [No Abstract]   [Full Text] [Related]  

  • 40. B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis.
    Craig VJ; Cogliatti SB; Arnold I; Gerke C; Balandat JE; Wündisch T; Müller A
    Leukemia; 2010 Jun; 24(6):1186-96. PubMed ID: 20428202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.